- Report
- June 2025
- 296 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 115 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- September 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- August 2024
- 266 Pages
Global
From €1214EUR$1,403USD£1,000GBP
- Report
- October 2024
- 129 Pages
Global
From €4165EUR$4,650USD£3,550GBP
- Report
- April 2025
Global
From €4389EUR$4,900USD£3,741GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 186 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 194 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 189 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- December 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 184 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP

The Neurotech market is a subset of the Neurology Devices industry, focusing on the development and commercialization of products and services related to the diagnosis, treatment, and management of neurological disorders. Neurotech products range from medical devices such as brain-computer interfaces, deep brain stimulation systems, and neuroprosthetics, to software and digital health solutions such as brain-computer interfaces, virtual reality, and artificial intelligence. Neurotech companies are also developing novel treatments for neurological disorders, such as gene therapy, stem cell therapy, and gene editing.
The Neurotech market is driven by advances in technology, increasing prevalence of neurological disorders, and growing demand for personalized treatments. Neurotech companies are also leveraging the power of data to develop more effective treatments and improve patient outcomes.
Notable companies in the Neurotech market include NeuroPace, NeuroMetrix, BrainScope, NeuroSigma, NeuroVista, and NeuroSens. Show Less Read more